Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/kyvernas-kyv-101-receives-us-fda-ind-clearance-for-treatment-of-patients-with-treatment-refractory-stiff-person-syndrome-in-the-kysa-8-phase-2-trial-302177671.html
https://www.fiercebiotech.com/biotech/kyverna-reports-relapse-early-stage-car-t-lupus-trial
https://www.prnewswire.com/news-releases/kyverna-therapeutics-to-attend-the-2024-american-academy-of-neurology-aan-annual-meeting-in-denver-co-with-data-on-kyv-101-in-the-treatment-of-patients-with-neurological-autoimmune-diseases-302114930.html
https://www.prnewswire.com/news-releases/kyverna-therapeutics-provides-business-update-and-reports-full-year-2023-financial-results-302100073.html
https://www.prnewswire.com/news-releases/kyverna-therapeutics-and-stanford-university-agree-to-evaluate-kyv-101-in-patients-with-non-relapsing-and-progressive-forms-of-multiple-sclerosis-302083613.html
https://www.prnewswire.com/news-releases/kyverna-therapeutics-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares-302059964.html
https://www.fiercebiotech.com/biotech/kyverna-ceo-fresh-319m-ipo-says-were-next-phase-medicine
https://www.fiercebiotech.com/biotech/kyverna-overshoots-even-its-raised-ipo-expectations-bringing-319m-oversized-offering
https://www.prnewswire.com/news-releases/kyverna-therapeutics-announces-pricing-of-upsized-initial-public-offering-302056924.html
https://www.fiercebiotech.com/biotech/kyverna-ups-ipo-roughly-300-million-after-seeing-peers-land-upsized-raises